Back
Lumentum Holdings 10K Form
Sell
42
LITE
Lumentum Holdings
Last Price:
$66.59
Seasonality Move:
2.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | LITE/Lumentum Holdings Quarterly |
2023-05-09 | 10Q | LITE/Lumentum Holdings Quarterly |
2023-02-09 | 10Q | LITE/Lumentum Holdings Quarterly |
2022-11-08 | 10Q | LITE/Lumentum Holdings Quarterly |
2022-05-04 | 10Q | LITE/Lumentum Holdings Quarterly |
2022-02-03 | 10Q | LITE/Lumentum Holdings Quarterly |
Receive LITE News And Ratings
See the #1 stock for the next 7 days that we like better than LITE
LITE Financial Statistics
Sales & Book Value
Annual Sales: | $1.4B |
---|---|
Cash Flow: | $-15.9M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.62 |
Price / Book: | 5.46 |
Profitability
EPS (TTM): | -7.69000 |
---|---|
Net Income (TTM): | $-522.8M |
Gross Margin: | $251.5M |
Return on Equity: | -50.46% |
Return on Assets: | -12.61% |
Lumentum Holdings Earnings Forecast
Key Lumentum Holdings Financial Ratios
-
The Gross Profit Margin over the past 13 years for LITE is 18.50%.
-
The Selling, General & Administrative Expenses for LITE have been equal to 22.86% of Gross Profit Margin.
-
The Research & Development expenses have been 22.23% of Revenue.
-
The Net Earning history of LITE is -40.21% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Lumentum Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | LITE |
CUSIP: | 55024U |
Website: | lumentum.com |
Debt
Debt-to-Equity Ratio: | 2.95 |
---|---|
Current Ratio: | 4.76 |
Quick Ratio: | 3.24 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 18.42 |
LITE Technical Analysis vs Fundamental Analysis
Sell
42
Lumentum Holdings (LITE)
is a Sell
Is Lumentum Holdings a Buy or a Sell?
-
Lumentum Holdings stock is rated a SellThe current Lumentum Holdings [LITE] share price is $68.83. The Score for LITE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.